Yuichi Maruki

Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

Koji Abe, Masashi Aoki, Shoji Tsuji et al. · The Lancet Neurology · 2017 · 925 citations

Life Sciences, Neurology, Neuroscience +11

Constitutively Activated ALK2 and Increased SMAD1/5 Cooperatively Induce Bone Morphogenetic Protein Signaling in Fibrodysplasia Ossificans Progressiva

Toru Fukuda, Masakazu Kohda, Kazuhiro Kanomata et al. · Journal of Biological Chemistry · 2008 · 209 citations · Full text

Medicine, Genetics, Molecular Genetics +17

Sodium, ATP, and intracellular pH transients during reversible complete ischemia of dog cerebrum.

Scott M. Eleff, Yuichi Maruki, Lee H. Monsein et al. · Stroke · 1991 · 76 citations

Life Sciences, Neuroscience, Physiology +16

A unique mutation of ALK2, G356D, found in a patient with fibrodysplasia ossificans progressiva is a moderately activated BMP type I receptor

Toru Fukuda, Kazuhiro Kanomata, Junya Nojima et al. · Biochemical and Biophysical Research Communications · 2008 · 67 citations

Life Sciences, Genetics, Molecular Biology +13

A novel mutation of ALK2, L196P, found in the most benign case of fibrodysplasia ossificans progressiva activates BMP-specific intracellular signaling equivalent to a typical mutation, R206H

Satoshi Ohte, Masashi Shin, Hiroki Sasanuma et al. · Biochemical and Biophysical Research Communications · 2011 · 49 citations

Life Sciences, Genetics, Molecular Genetics +12